LY2090314
Kwaliteit
ISO Gecertificeerd
Levering
24-48 uur
Technische Specificaties
603288-22-8
C12415-5mg
GSK-3
PI3K/Akt/mTOR
C1CCN (CC1) C (=O) N2CCN3C=C (C4=CC (=CC (=C43) C2) F) C5=C (C (=O) NC5=O) C6=CN=C7N6C=CC=C7
C28H25FN6O3
LY2090314 is a potent GSK-3 inhibitor for GSK-3α/β with IC50 of 1.5 nM/0.9 nM; may improve the efficacy of platinum-based chemotherapy regimens. LY2090314 is highly selective towards GSK3 as demonstrated by its fold selectivity relative to a large panel of kinases.
2 years -80 in solvent
Beschrijving
LY2090314 Beschikbaar in 5 mg. Wordt geleverd met droogijs. Bestel eenvoudig online met snelle levering.
Specificaties
Recent bekeken producten
Anti-TNF-α (Adalimumab), humanized Antibody
A1048-100
100 µg
PEPTIC DIGEST OF ANIMAL TISSUE (MEAT PEPTONE)
P16-102-01
500 g
GelRed® Agarose LE
#41029-5G
1x 5 g
HT115 (DE3) Super Competent Cells
D1045S
10x 100 μL
HT115
ACC-130
10 Tubes
Rat Reticulon-4 receptor, RTN4R ELISA Kit
MBS9325746-01
48 Well
Starfish Genomic DNA
GSF-390
0.025 mg
NPM2
570475-01
50 µg
Recent gezochte producten
Anti-EGFR Antibody (aa1048-1077) IHC-plus
MBS2400374-01
0.2 mL
BIBR-1048 10mg
A10139-10
10 mg
BIBR-1048 100mg
A10139-100
100 mg
BIBR-1048 10mM * 1mL in DMSO
A10139-10mM-D
10 mM x 1mL in DMSO
MK-2048 100mg
A11135-100
100 mg
Ro 61-8048 100mg
A12833-100
100 mg
MMV390048 100mg
A13566-100
100 mg
VCE-004.8 100mg
A18549-100
100 mg